HomeCompareSTJO vs JNJ

STJO vs JNJ: Dividend Comparison 2026

STJO yields 16666.67% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 STJO wins by $8601297707047409664.00M in total portfolio value
10 years
STJO
STJO
● Live price
16666.67%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8601297707047409664.00M
Annual income
$8,500,961,637,704,150,000,000,000.00
Full STJO calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — STJO vs JNJ

📍 STJO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSTJOJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, STJO + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
STJO pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

STJO
Annual income on $10K today (after 15% tax)
$1,416,666.67/yr
After 10yr DRIP, annual income (after tax)
$7,225,817,392,048,527,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, STJO beats the other by $7,225,817,392,048,527,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of STJO + JNJ for your $10,000?

STJO: 50%JNJ: 50%
100% JNJ50/50100% STJO
Portfolio after 10yr
$4300648853523704832.00M
Annual income
$4,250,480,818,852,075,000,000,000.00/yr
Blended yield
98.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

STJO
No analyst data
Altman Z
1.2
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

STJO buys
0
JNJ buys
0
No recent congressional trades found for STJO or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSTJOJNJ
Forward yield16666.67%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$8601297707047409664.00M$30.5K
Annual income after 10y$8,500,961,637,704,150,000,000,000.00$4,749.88
Total dividends collected$8594666089931243520.00M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: STJO vs JNJ ($10,000, DRIP)

YearSTJO PortfolioSTJO Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$1,677,367$1,666,666.67$10,594$274.49+$1.67MSTJO
2$263,066,849$261,272,066.46$11,294$360.69+$263.06MSTJO
3$38,576,943,838$38,295,462,310.00$12,133$476.91+$38576.93MSTJO
4$5,289,656,888,585$5,248,379,558,677.81$13,156$635.42+$5289656.88MSTJO
5$678,235,585,150,030$672,575,652,279,244.40$14,432$854.61+$678235585.14MSTJO
6$81,321,145,183,775,540$80,595,433,107,665,010.00$16,056$1,162.76+$81321145183.76MSTJO
7$9,118,299,079,523,715,000$9,031,285,454,177,076,000.00$18,175$1,604.53+$9118299079523.70MSTJO
8$956,159,646,381,740,000,000$946,403,066,366,649,700,000.00$21,009$2,252.68+$956159646381740.00MSTJO
9$93,772,027,423,605,150,000,000$92,748,936,601,976,690,000,000.00$24,911$3,229.73+$93772027423605152.00MSTJO
10$8,601,297,707,047,409,000,000,000$8,500,961,637,704,150,000,000,000.00$30,458$4,749.88+$8601297707047409664.00MSTJO

STJO vs JNJ: Complete Analysis 2026

STJOStock

St. Joseph, Inc., through its subsidiary, Staf*Tek Services, Inc., engages in the recruitment and placement of professional technical personnel, as well as finance and accounting personnel on a temporary and permanent basis primarily in the Tulsa, Oklahoma area. It provides its customers with employee candidates with information technology skills in areas ranging from multiple platform systems integration to end-user support, including specialists in programming, networking, systems integration, and database design, as well as help desk support comprising senior and entry level finance and accounting candidates. The company also offers computer training, online assessments, and certification in approximately 50 skill sets. It provides its services to a range of assignments from technical one-person assignments to major projects, such as Internet/Intranet development, desktop applications development, project management, enterprise systems development, SAP implementation, and mainframe projects. The company was formerly known as St. Joseph Energy, Inc. and changed its name to St. Joseph, Inc. in November 2003. St. Joseph, Inc. was founded in 1997 and is based in McKinney, Texas.

Full STJO Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this STJO vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

STJO vs SCHDSTJO vs JEPISTJO vs OSTJO vs KOSTJO vs MAINSTJO vs ABBVSTJO vs MRKSTJO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.